Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease

N Engl J Med. 2002 Apr 11;346(15):1174-5. doi: 10.1056/NEJM200204113461517.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Botulinum Toxins, Type A / therapeutic use*
  • Deglutition Disorders / drug therapy*
  • Deglutition Disorders / etiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuromuscular Agents / therapeutic use*
  • Parkinson Disease / complications*
  • Parkinson Disease / drug therapy

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A